Mounjaro Takes the Lead Over Ozempic

Mounjaro Takes the Lead Over Ozempic

A new study reveals that Eli Lilly’s Mounjaro significantly outperforms Novo Nordisk’s Ozempic in promoting weight loss, despite both drugs sharing similar side effects and dropout rates.Key FindingsThe research, published in JAMA Internal Medicine,...
Facebook
Instagram